A Study to Investigate the Relative Bioavailability and Food Effect of a Fixed-Dose Combination Tablet Containing Zanubrutinib and Sonrotoclax (BG-71332) in Healthy Adults
Clinical trial NCT07141511 · COMPLETED
Trial details
- NCT number
- NCT07141511
- Sponsor
- BeOne Medicines
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-24
- Primary completion
- 2026-02-23
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.